Acceleron Pharma Inc.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 85170
 
  
 
C07K PEPTIDES 7366
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 16151
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 643
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 5201
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 396
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 3122
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0009,872 ANTAGONISTS OF ACTRIIB AND USES FOR INCREASING RED BLOOD CELL LEVELSJul 18, 17Jan 11, 18[A61K, C07K]
2017/0354,731 ALK1 RECEPTOR AND LIGAND ANTAGONISTS AND USES THEREOFAug 25, 17Dec 14, 17[A61K, C07K]
2017/0327,800 METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESISJul 28, 17Nov 16, 17[A61K, C12N]
2017/0190,784 ACTIVIN-ACTRIIA ANTAGONISTS AND USES FOR TREATING MULTIPLE MYELOMAJan 11, 17Jul 06, 17[A61K, C07K]
2017/0145,074 ACTIVIN-ACTRIIA ANTAGONISTS AND USES FOR TREATING OR PREVENTING BREAST CANCERNov 30, 16May 25, 17[A61K, C07K]
2017/0137,503 ANTAGONISTS OF BMP9, BMP10, ALK1 AND OTHER ALK1 LIGANDS, AND USES THEREOFAug 24, 16May 18, 17[A61K, C07K]
2017/0137,791 METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESISJan 23, 17May 18, 17[C12N]
2016/0319,254 ACTIVIN-ACTRIIA ANTAGONISTS FOR INHIBITING GERM CELL MATURATIONMay 06, 16Nov 03, 16[C12N]
2016/0287,664 COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSIONNov 21, 14Oct 06, 16[A61K, C07K]
2016/0279,197 METHODS FOR DOSING AN ACTRIIB ANTAGONIST AND MONITORING OF TREATED PATIENTSJan 25, 16Sep 29, 16[A61K, G01N, C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9919030 Follistatin fusion proteins and uses thereofFeb 13, 15Mar 20, 18[A61K, G01N, C07K]
9914762 BMP-ALK3 antagonists and uses for promoting bone growthFeb 02, 15Mar 13, 18[A61K, C12N, C07K]
9884900 Methods for treating Janus kinase-associated disorders by administering soluble transforming growth factor beta type II receptorAug 04, 16Feb 06, 18[A61K, C07K]
9850298 Methods for treating ulcers in thalassemia syndrome with an ActRIIB polypeptideJun 12, 15Dec 26, 17[A61K, A61P, C07K]
9809636 Methods for increasing red blood cell levels comprising administering BMP9Mar 14, 13Nov 07, 17[C07K]
9809637 Transforming growth factor beta receptor II fusion polypeptidesFeb 16, 16Nov 07, 17[A61K, C07K]
9790284 Methods for increasing thermogenic adipocytesApr 01, 14Oct 17, 17[A61K, C07K]
9745559 Method for decreasing the body fat content in a subject by administering an ActRIIB proteinJul 30, 15Aug 29, 17[A61K, C12N, C07K]
9624301 Polynucleotides encoding an actriib antibodyAug 11, 16Apr 18, 17[C07K]
9617319 ActRIIB proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapyApr 16, 14Apr 11, 17[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0152,490 USE OF ACTIVIN RECEPTOR-LIKE KINASE 1 (ALK-1) ANTAGONISTS IN THE TREATMENT OF CANCERAbandonedMar 27, 15Jun 01, 17[A61K, C12Q, C12N]
2017/0015,751 ACTRIIA BINDING AGENTS AND USES THEREOFAbandonedSep 30, 16Jan 19, 17[C07K]
2016/0318,983 METHODS FOR TREATING FATTY LIVER DISEASEAbandonedMay 06, 16Nov 03, 16[C07K]
2016/0264,681 METHODS FOR INCREASING ADIPONECTINAbandonedFeb 10, 16Sep 15, 16[C07K]
9403910 Polynucleotides encoding an actriib antibodyWithdrawnMar 14, 13Aug 02, 16[A61K, C07K]
2016/0199,458 METHODS OF PROMOTING FAT LOSS COMPRISING ADMINISTERING AN ALK7 INHIBITORAbandonedJan 08, 16Jul 14, 16[A61K]
2016/0115,209 CERBERUS/COCO DERIVATIVES AND USES THEREOFAbandonedJun 01, 15Apr 28, 16[C07K]
2015/0183,849 COMPOSITIONS AND METHODS FOR INCREASING SERUM HALF-LIFEAbandonedNov 07, 14Jul 02, 15[C07K]
2015/0056,199 TGF-BETA RECEPTOR TYPE II VARIANTS AND USES THEREOFAbandonedAug 21, 14Feb 26, 15[C07K]
2015/0010,555 COMPOSITIONS AND METHODS FOR INCREASING SERUM HALF-LIFEAbandonedApr 24, 14Jan 08, 15[C07K]
2014/0193,425 TREATMENT OF CANCER WITH ALK1 ANTAGONISTSAbandonedOct 04, 13Jul 10, 14[A61K, C07K]
2013/0344,067 ALK1 RECEPTOR AND LIGAND ANTAGONISTS AND USES THEREOFAbandonedMay 31, 13Dec 26, 13[A61K, C07K]
2013/0243,743 METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESISAbandonedOct 17, 12Sep 19, 13[A61K]
2013/0202,594 ALK1 Antagonists and Their Uses in Treating Renal Cell CarcinomaAbandonedFeb 01, 13Aug 08, 13[A61K]
2013/0039,910 METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND PERICYTE COMPOSITIONAbandonedApr 13, 12Feb 14, 13[A61K, A61P]
2013/0029,908 CERBERUS/COCO DERIVATIVES AND USES THEREOFAbandonedJun 26, 12Jan 31, 13[A61K, C12N, A61P, C07K]
2012/0121,576 ACTRIIA BINDING AGENTS AND USES THEREOFAbandonedNov 08, 11May 17, 12[A61K, A61P, C07K]
2012/0003,218 ANTAGONISTS OF ACTRIIB AND USES FOR INCREASING RED BLOOD CELL LEVELSAbandonedAug 25, 11Jan 05, 12[A61K, A61P]
2011/0129,469 METHODS FOR TREATING FATTY LIVER DISEASEAbandonedNov 03, 10Jun 02, 11[A61K, A61P]
2011/0070,233 ACTRIIB ANTAGONISTS AND DOSING AND USES THEREOFAbandonedSep 09, 10Mar 24, 11[A61K, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.